DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ultiva (Remifentanil) - Hyperreflexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hyperreflexia (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ultiva (Remifentanil) where reactions include hyperreflexia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-08-08

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Transient Tachypnoea of THE Newborn, Vomiting, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Phenobarbital TAB
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-10-27

Phenobarbital TAB
    Start date: 2011-10-27
    End date: 2011-10-31

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Morphine HCL Elixir
    Indication: Foetal Exposure During Pregnancy

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-07-30

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy

Phenobarbital TAB
    Start date: 2011-10-27
    End date: 2011-10-31

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Phenobarbital TAB
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-10-27

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-05-04

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Irritability, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Feeding Disorder, Drug Withdrawal Syndrome Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-05-04

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Phenobarbital TAB
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-10-27

Phenobarbital TAB
    Start date: 2011-10-27
    End date: 2011-10-31

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-02-28

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Irritability, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Feeding Disorder, Drug Withdrawal Syndrome Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-01-24

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Irritability, Transient Tachypnoea of THE Newborn, Vomiting, Premature Baby, Hyperreflexia, Feeding Disorder, Drug Withdrawal Syndrome Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Morphine HCL Elixir
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-01-19

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Maternal Drugs Affecting Foetus, Drug Withdrawal Syndrome Neonatal, Muscle Tightness, Caesarean Section, Anticonvulsant Drug Level Increased, Mean Cell Haemoglobin Increased, Blood Sodium Increased, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Vomiting Neonatal, Hyperreflexia, Tremor Neonatal, Irritability, Feeding Disorder, Feeding Disorder Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Morphine HCL Elixir
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01



Possible Ultiva side effects in male

Reported by a physician from Japan on 2011-11-30

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Irritability, Caesarean Section, Transient Tachypnoea of THE Newborn, Vomiting, Premature Baby, Foetal Exposure During Pregnancy, Hyperreflexia, Feeding Disorder, Drug Withdrawal Syndrome Neonatal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017